Active Ingredient(s): Fenfluramine Hydrochloride
FDA Approved: * June 25, 2020
Pharm Company: * ZOGENIX INC
Category: Diet / Weight Loss

Fenfluramine, sold under the brand name Fintepla, is a medication used for the treatment of seizures associated with Dravet syndrome in people age two and older.[2][3] The most common adverse reactions include decreased appetite; drowsiness, sedation and lethargy; diarrhea; constipation; abnormal echocardiogram; fatigue or lack of energy; ataxia (lack of coordination), balance disorder, gait disturbance (trouble with walking); increased blood pressure; drooling... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Fintepla 2.2 mg/ml Oral Solution
NDC: 43376-322
Zogenix, Inc.

Related Brands

Drugs with the same active ingredients